β-Casomorphin, human

    β-Casomorphin, human is an opioid peptide, acts as an agonist of opioid receptor.

    Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
    β-Casomorphin, human(CAS 102029-74-3)

    CAT No: R1792

    CAS No: 102029-74-3

    Quick InquiryCustom Peptide Synthesis

    cGMP Peptide

    Registration of APIs CMC information required for an IND

    IND and NDA support Drug master files (DMF) filing

    Specification Technical Data Publications Customer reviews and Q&A
    Synonyms/Alias102029-74-3;H-Tyr-Pro-Phe-Val-Glu-Pro-Ile-OH;beta-Casomorphin, human;Casomorphin;2-[[1-[2-[[2-[[2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoic acid;DTXSID50403148;Tyrosylprolylphenylalanylvalyl-alpha-glutamylprolylisoleucine;(S)-4-((S)-2-((S)-2-((S)-1-((S)-2-Amino-3-(4-hydroxyphenyl)Propanoyl)pyrrolidine-2-carboxamido)-3-phenylPropanamido)-3-methylbutanamido)-5-((S)-2-(((1S,2S)-1-carboxy-2-methylbutyl)carbamoyl)pyrrolidin-1-yl)-5-oxopentanoic acid;b-Casomorphin, human;beta-Casomorphin human;??-Casomorphin, human;beta-Casomorphin (human);Human ??-casomorphin 7;Human beta casomorphin 7;b-Casomorphin, human(TFA);DTXCID70354002;CHEBI:172843;AKOS040759189;FC73316;2-{[1-(2-{2-[2-({1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl}formamido)-3-phenylpropanamido]-3-methylbutanamido}-4-carboxybutanoyl)pyrrolidin-2-yl]formamido}-3-methylpentanoic acid;DA-59355;TS-09693;Human b-casomorphin 7Human b-casomorphin 7;
    M.F/FormulaC44H61N7O11
    M.W/Mr.864
    SequenceOne Letter Code:YPFVEPX
    Three Letter Code:H-DL-Tyr-DL-Pro-DL-Phe-DL-Val-DL-Glu-DL-Pro-DL-xiIle-OH
    Purity>98%
    Shipping ConditionShipped at room temperature
    InChIInChI=1S/C44H61N7O11/c1-5-26(4)37(44(61)62)49-40(57)34-14-10-22-51(34)43(60)31(19-20-35(53)54)46-41(58)36(25(2)3)48-38(55)32(24-27-11-7-6-8-12-27)47-39(56)33-13-9-21-50(33)42(59)30(45)23-28-15-17-29(52)18-16-28/h6-8,11-12,15-18,25-26,30-34,36-37,52H,5,9-10,13-14,19-24,45H2,1-4H3,(H,46,58)(H,47,56)(H,48,55)(H,49,57)(H,53,54)(H,61,62)
    InChI KeyADBHAJDGVKLXHK-UHFFFAOYSA-N

    1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

    2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

    3. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

    4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

    5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

    Write a review Ask a question
    My Review for β-Casomorphin, human

    Required fields are marked with *

    • Basic Information
    ×
    Ask a Question for β-Casomorphin, human

    Required fields are marked with *

    • Basic Information
    ×
    Useful Tools

    Peptide Calculator

    Abbreviation List

    Peptide Glossary

    If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.

    Featured Services
    Hot Products

    • Terlipressin Acetate

      Terlipressin acetate is a vasopressin analogue with potent vasoactive properties. Terlipressin acetate is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.

      Inquiry

    • Lanreotide Acetate

      Lanreotide is a a synthetic cyclic octapeptide analogue of somatostatin. Lanreotide inhibits the secretion of growth hormone (GH) by binding to pituitary somatostatin receptors, and may inhibit the release of various other hormones, including thyroid stimulating hormone (TSH) and the gastroenteropancreatic hormones insulin, glucagon and gastrin.

      Inquiry

    • Terlipressin

      Terlipressin is a synthetic triglycyllysine derivative of vasopressin with vasoconstrictive, antihemorrhagic, and antidiuretic properties. Upon intravenous administration, terlipressin, an inactive prodrug, is biotransformed to its active moiety, lysine vasopressin (LVP), a nonselective vasopressin analogue with affinity for vasopressin receptors V1 (V1a), V2 and V3 (V1b). As a V1 agonist, terlipressin increases systemic vascular resistance, particularly in the splanchnic area, resulting in a decrease of portal pressure. V1 binding also promotes platelet aggregation and glycogenolysis, while V3 binding induces adrenocorticotropic hormone (ACTH) secretion. Compared to vasopressin, terlipressin has a minimal effect on V2 receptors, which are responsible for promotion of water reabsorption in the collecting ducts of the kidney via stimulation of cyclic AMP production.

      Inquiry

    • Buserelin Acetate

      Buserelin Acetate is an agonist of gonadotropin-releasing hormone receptor(GnRHR). Buserelin is a synthetic luteinizing hormone–releasing hormone (LHRH) analog.

      Inquiry

    • Antide

      Antide acetate (Ac-AA10-NH2) is an LHRH antagonist and represses LH and FSH release from the pituitary gland. It shows a high antiovulatory activity and releases negligible histamine.

      Inquiry

    • Teduglutide

      Teduglutide is a polypeptide consisting of 33 amino acids. It is glucagon-like peptide-2 (GLP-2) analogue that is used for the treatment of short bowel syndrome.

      Inquiry

    • Glucagon

      Glucagon (Porcine glucagon) is a peptide hormone, produced by pancreatic α-cells. Glucagon stimulates gluconeogenesis. Glucagon decreases the activity of HNF-4. Glucagon increases HNF4α phosphorylation.

      Inquiry

    • Thymosin β4 Acetate

      Thymosin β4 is a 43 amino acid peptide which is regarded as the main intracellular G-actin sequestering peptide. Extracellular thymosin β4 may contribute to physiological processes such as angiogenesis, wound healing and regulation of inflammation.

      Inquiry

    • Elcatonin Acetate

      Elcatonin acetate inhibits the absorption and autolysis of bones, thus leads to blood calcium descending. In addition, it inhibits the bone salts dissolving and transferring and promotes the excretion of calcium and phosphorus in urine.

      Inquiry

    • Somatostatin

      Somatostatin is a tetradecapeptide which can suppress the growth hormone (GH) secretion and control the pituitary hormone secretion in human CNS.

      Inquiry

    • Terlipressin Acetate

      Terlipressin acetate is a vasopressin analogue with potent vasoactive properties. Terlipressin acetate is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.

      Inquiry

    • Lanreotide Acetate

      Lanreotide is a a synthetic cyclic octapeptide analogue of somatostatin. Lanreotide inhibits the secretion of growth hormone (GH) by binding to pituitary somatostatin receptors, and may inhibit the release of various other hormones, including thyroid stimulating hormone (TSH) and the gastroenteropancreatic hormones insulin, glucagon and gastrin.

      Inquiry

    • Terlipressin

      Terlipressin is a synthetic triglycyllysine derivative of vasopressin with vasoconstrictive, antihemorrhagic, and antidiuretic properties. Upon intravenous administration, terlipressin, an inactive prodrug, is biotransformed to its active moiety, lysine vasopressin (LVP), a nonselective vasopressin analogue with affinity for vasopressin receptors V1 (V1a), V2 and V3 (V1b). As a V1 agonist, terlipressin increases systemic vascular resistance, particularly in the splanchnic area, resulting in a decrease of portal pressure. V1 binding also promotes platelet aggregation and glycogenolysis, while V3 binding induces adrenocorticotropic hormone (ACTH) secretion. Compared to vasopressin, terlipressin has a minimal effect on V2 receptors, which are responsible for promotion of water reabsorption in the collecting ducts of the kidney via stimulation of cyclic AMP production.

      Inquiry

    • Buserelin Acetate

      Buserelin Acetate is an agonist of gonadotropin-releasing hormone receptor(GnRHR). Buserelin is a synthetic luteinizing hormone–releasing hormone (LHRH) analog.

      Inquiry

    • Antide

      Antide acetate (Ac-AA10-NH2) is an LHRH antagonist and represses LH and FSH release from the pituitary gland. It shows a high antiovulatory activity and releases negligible histamine.

      Inquiry

    About us

    Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

    From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

    FAQ
    Trusted By Over 1500

    Our Customers

    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    image
    Get in touch with us

    Copyright © 2025 Creative Peptides. All rights reserved.